Gastroenterologie
a hepatologie

Hepatocellular carcinoma - diagnosis and treatment from the medical oncology perspective

Jiří Tomášek ^Orcid.org  , Štěpán Tuček ^Orcid.org  , Tomáš Andrašina ^{Orcid.org  1}

+ Affiliation
¹ Department of Radiology and Nuclear Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic

Summary

Hepatocellular carcinoma (HCC) in the Czech Republic represents a small group of tumours. Unlike other countries, in the Czech Republic screening is of limited value. However, it has been recommended by the expert panel for groups at major risk-patients with hepatic cirrhosis and patients with hepatitis B andC. The choice of a method of treatment and its success depend on the extent of the malignant disease and the functional impairment of remaining liver parenchyma. The curative treatment includes surgical resection or radiofrequency ablation, and liver transplantation. The palliative methods proven as effective include trans-arterial chemoembolization(TACE), percutaneous ethanol injection (PEI), and the only systemic treatment, with sorafenib. The diagnostic and therapeutic workup uses a multidisciplinary approach and belongs to specialized centres. Thank to the multidisciplinary approach and the improvement in communication between various institutions, the optimal procedure has become achievable for more patients.

Keywords

hepatocellular carcinoma, liver transplantation

---

Obr. 1: CT vyšetření s kontrastní látkou, arteriální fáze, hypervaskularizované ložisko charakteru HCC v segmentu S6

---

---

Obr. 2: CT vyšetření s kontrastní látkou, portovenózní fáze, hypervaskularizované ložisko charakteru HCC v segmentu S6

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users